Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1743studies shown

Showing 217-228 of 1,743

Behavioral study icon

CompletedNCT03035110

A Feasibility Study to Evaluate Suicide prevention Group in Inpatient Settings

This study is completed in the United Kingdom. It is testing suicide prevention Group for Suicide prevention.

In United Kingdom

SuicidalityBehavioralFrom 18 Years to 65 Years

Countries: United Kingdom
Sponsor: University of Essex
Condition: Suicidality

Biological study icon

TerminatedISRCTN95019245

A five year non-residential multi-centre observational study conducted to track any changes in mouth level exposure and salivary and urinary biomarkers from healthy smokers smoking in their normal environment

This study was terminated in the United Kingdom and in Germany. It focuses on Addiction.

In United Kingdom

AddictionOther

Countries: United Kingdom, Germany
Sponsor: British American Tobacco (Investments) Ltd (UK)
Condition: Addiction

Behavioral study icon

CompletedNCT02551445

A fMRI Study of the Effects of Meal-support in Eating disorders.

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

Eating disordersBehavioralFrom 19 Years to 60 Years

Countries: United Kingdom
Sponsor: King's College London
Condition: Eating disorders

Other study type icon

UnknownNCT05780853

A Game-based Neurodevelopmental Assessment for Young Children

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

ADHDDiagnostic TestFrom 3 Years to 8 Years

Countries: United Kingdom
Sponsor: Brightlobe Limited
Condition: ADHD

Drug study icon

CompletedNCT00500201

A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.

This study is completed in the United Kingdom. It focuses on Schizophrenia.

In United Kingdom

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United Kingdom
Sponsor: GlaxoSmithKline
Condition: Schizophrenia

Drug study icon

CompletedNCT00700427

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

ADHDDrugFrom 18 Years to 50 Years

Countries: France, United Kingdom, Switzerland, ...
Sponsor: Eli Lilly and Company
Condition: ADHD

Drug study icon

CompletedNCT02782104

A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

DepressionDrugOver 18 Years

Countries: United States, Australia, France, ...
Sponsor: Janssen Research & Development, LLC
Condition: Depression

Drug study icon

CompletedNCT02497287

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom

DepressionDrugOver 18 Years

Countries: United States, Australia, France, ...
Sponsor: Janssen Research & Development, LLC
Condition: Depression

Drug study icon

CompletedEUCTR 2007-003035-22

A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom

SchizophreniaDrug

Countries: France, United Kingdom, Belgium, ...
Sponsor: ACADIA Pharmaceuticals Inc.
Condition: Schizophrenia

Drug study icon

CompletedEUCTR 2005-003745-14

A Multi-centre, Double-blind, Randomised Withdrawal, Parallel-group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR®) as Monothe...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom

DepressionDrug

Countries: United Kingdom, Finland, Germany, ...
Sponsor: AstraZeneca AB
Condition: Depression

Drug study icon

SuspendedEUCTR 2010-024371-12

A multicenter, Double-blind 58 week Rollover Study to assess the Safety and Tolerability of BMS-820836 in Patients with Treatment Resistant Major Depression.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom

DepressionDrug

Countries: United Kingdom, Austria, Finland, ...
Sponsor: Bristol-Myers Squibb International Corporation
Condition: Depression

Drug study icon

CompletedEUCTR 2005-002169-35

A Multicenter, Double-Blind, Flexible-Dose, 6-Month Extension Trial Comparing the safety and Efficacy of Asenapine With Olanzapine in Subjects who Completed Protocol 25543

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom

SchizophreniaDrug

Countries: United Kingdom, Czechia, Finland, ...
Sponsor: NV Organon
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.